September 18-19 / 28-29, 2017 : Training in development of therapeutic antibodies : from research to market
Development and production of therapeutic antibodies require specific expertise proper to biotechnologies.
MabDesign organizes a training session dedicated to the technologic, methodologic and regulatory approaches in the field of monoclonal antibodies (mAbs). The objective is to present an overview of the mAb development cycle.
Four training days compose an unique training program. The newly created “à la carte” training program option allow the learners to build their training path depending their topic of interest. Generation and engineering of mAbs, preclinical safety assessment and bioethical considerations, the upstream and downstream processes, completed with viral safety, and finally, clinical trials from first-in-man to pharmacovigilance are the topics proposed by MabDesign during this training session.